217 related articles for article (PubMed ID: 19789841)
1. Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts.
Balandin TG; Edelweiss E; Andronova NV; Treshalina EM; Sapozhnikov AM; Deyev SM
Invest New Drugs; 2011 Feb; 29(1):22-32. PubMed ID: 19789841
[TBL] [Abstract][Full Text] [Related]
2. Barnase as a new therapeutic agent triggering apoptosis in human cancer cells.
Edelweiss E; Balandin TG; Ivanova JL; Lutsenko GV; Leonova OG; Popenko VI; Sapozhnikov AM; Deyev SM
PLoS One; 2008 Jun; 3(6):e2434. PubMed ID: 18560598
[TBL] [Abstract][Full Text] [Related]
3. [Immunocytochemical visualization of P185(HER2) receptor by antibody fused with dibarnase and conjugate of barstar with colloidal gold].
Ivanova IuL; Edelweiss EF; Leonova OG; Balandin TG; Popenko VI; Deev SM
Mol Biol (Mosk); 2013; 47(5):806-17. PubMed ID: 25509353
[TBL] [Abstract][Full Text] [Related]
4. Application of fusion protein 4D5 scFv-dibarnase:barstar-gold complex for studying P185HER2 receptor distribution in human cancer cells.
Ivanova JL; Edelweiss EF; Leonova OG; Balandin TG; Popenko VI; Deyev SM
Biochimie; 2012 Aug; 94(8):1833-6. PubMed ID: 22531627
[TBL] [Abstract][Full Text] [Related]
5. A novel fully human antitumor immunoRNase resistant to the RNase inhibitor.
Riccio G; D'Avino C; Raines RT; De Lorenzo C
Protein Eng Des Sel; 2013 Mar; 26(3):243-8. PubMed ID: 23232187
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu.
Cao Y; Mohamedali KA; Marks JW; Cheung LH; Hittelman WN; Rosenblum MG
Mol Cancer Ther; 2013 Jun; 12(6):979-91. PubMed ID: 23493312
[TBL] [Abstract][Full Text] [Related]
7. Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studies.
Cao Y; Marks JW; Liu Z; Cheung LH; Hittelman WN; Rosenblum MG
Oncogene; 2014 Jan; 33(4):429-39. PubMed ID: 23376850
[TBL] [Abstract][Full Text] [Related]
8. Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B.
Cheung LH; Zhao Y; Alvarez-Cienfuegos A; Mohamedali KA; Cao YJ; Hittelman WN; Rosenblum MG
J Exp Clin Cancer Res; 2019 Jul; 38(1):332. PubMed ID: 31362764
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of a recombinant human beta defensin 2 fusion protein targeting the epidermal growth factor receptor: in vitro study.
Zhang M; Qiu Z; Li Y; Yang Y; Zhang Q; Xiang Q; Su Z; Huang Y
Appl Microbiol Biotechnol; 2013 May; 97(9):3913-23. PubMed ID: 22903275
[TBL] [Abstract][Full Text] [Related]
11. A fusogenic dengue virus-derived peptide enhances antitumor efficacy of an antibody-ribonuclease fusion protein targeting the EGF receptor.
Kiesgen S; Liebers N; Cremer M; Arnold U; Weber T; Keller A; Herold-Mende C; Dyckhoff G; Jäger D; Kontermann RE; Arndt MA; Krauss J
Protein Eng Des Sel; 2014 Oct; 27(10):331-7. PubMed ID: 25301960
[TBL] [Abstract][Full Text] [Related]
12. The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.
Woitok M; Klose D; Niesen J; Richter W; Abbas M; Stein C; Fendel R; Bialon M; Püttmann C; Fischer R; Barth S; Kolberg K
Cancer Lett; 2016 Oct; 381(2):323-30. PubMed ID: 27502168
[TBL] [Abstract][Full Text] [Related]
13. Reduced Tumor Volume and Increased Necrosis of Human Breast Tumor Xenograft in Mice Pretreated by a Cocktail of Three Specific Anti-HER2 scFvs.
Nejatollahi F; Nadimi E; Noorafshan A; Moazen S; Alizadeh AM; Khalighfard S; Sahebkar A
Curr Protein Pept Sci; 2024; 25(5):409-418. PubMed ID: 38018211
[TBL] [Abstract][Full Text] [Related]
14. A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomas.
De Lorenzo C; Arciello A; Cozzolino R; Palmer DB; Laccetti P; Piccoli R; D'Alessio G
Cancer Res; 2004 Jul; 64(14):4870-4. PubMed ID: 15256457
[TBL] [Abstract][Full Text] [Related]
15. Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation.
Wang JH; Forterre AV; Zhao J; Frimannsson DO; Delcayre A; Antes TJ; Efron B; Jeffrey SS; Pegram MD; Matin AC
Mol Cancer Ther; 2018 May; 17(5):1133-1142. PubMed ID: 29483213
[TBL] [Abstract][Full Text] [Related]
16. Fusion of apoptosis-related protein Cytochrome c with anti-HER-2 single-chain antibody targets the suppression of HER-2+ breast cancer.
Lu D; Guo Y; Hu Y; Wang M; Li C; Gangrade A; Chen J; Zheng Z; Guo J
J Cell Mol Med; 2021 Nov; 25(22):10638-10649. PubMed ID: 34697906
[TBL] [Abstract][Full Text] [Related]
17. A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer.
Zhou M; Wang X; Xia J; Cheng Y; Xiao L; Bei Y; Tang J; Huang Y; Xiang Q; Huang S
Int J Nanomedicine; 2020; 15():3087-3098. PubMed ID: 32431503
[TBL] [Abstract][Full Text] [Related]
18. A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity.
Guo XF; Zhu XF; Shang Y; Zhang SH; Zhen YS
Clin Cancer Res; 2010 Apr; 16(7):2085-94. PubMed ID: 20332319
[TBL] [Abstract][Full Text] [Related]
19. A new RNase-based immunoconjugate selectively cytotoxic for ErbB2-overexpressing cells.
De Lorenzo C; Nigro A; Piccoli R; D'Alessio G
FEBS Lett; 2002 Apr; 516(1-3):208-12. PubMed ID: 11959134
[TBL] [Abstract][Full Text] [Related]
20. Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells.
D'Avino C; Paciello R; Riccio G; Coppola C; Laccetti P; Maurea N; Raines RT; De Lorenzo C
Protein Eng Des Sel; 2014 Mar; 27(3):83-8. PubMed ID: 24421342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
